Bruker Sets New Standards in Preclinical Imaging Software with ParaVision 6
Bruker Sets New Standards in Preclinical Imaging Software with ParaVision 6
Higher Productivity, Increased Performance and Easy Access to MRI for Translational and Pharmaceutical Research
SAVANNAH, Ga.--(BUSINESS WIRE)-- At the 2013 World Molecular Imaging Congress (WMIC, www.wmicmeeting.org), Bruker (NAS: BRKR) today introduces its ParaVision®6 software, setting new standards in preclinical MRI software that delivers significantly enhanced productivity for both, routine users and accomplished experts. A redefined workflow introduces optimized, application-oriented experimental protocols, an intuitive, interactive 3D scan planning viewport, and automatic reporting. Thanks to its DICOM-based data exchange module, ParaVision 6 seamlessly integrates with data from multimodal imaging studies employed in many preclinical research labs.
Delivering a quantum leap in ease of use, the redesigned ParaVision 6 workflow is designed with preclinical imaging in mind, featuring a newly developed user interface and easy parameter handling. A guided imaging workflow produces consistent results and lowers the learning curve for biomedical researchers new to MRI. A context-sensitive view reduces complexity by visualizing only parameters relevant to the operations at hand, ensuring intuitive and focused operation.
ParaVision 6 includes an extensive set of routine and advanced imaging sequences, supports seamless integration of parallel transmission techniques and incorporates a unique, integrated field map-based shimming procedure. Integrated, real-time optimization features enable dynamic adjustment of parameters during scanning, provide integration of navigator scans, and on-the-fly, automatically calculated Shinnar-LeRoux RF pulses for optimum slice profiles. In addition, automatic hardware recognition improves the set-up and reliability of the MRI system.
"With its innovative workflow concept, ParaVision 6 opens the door for preclinical MRI technology into new labs in pharma and translational research, while at the same time significantly increasing the productivity of research MRI users who welcome automated execution routines," stated Dr. Wulf I. Jung, President of Bruker's Preclinical Imaging Division.
ParaVision 6 is designed to benefit all modern Bruker MRI platforms from AVANCE™ II to AVANCE III HD, as well as ICON™ benchtop MRI and MPI (magnetic particle imaging) systems. AVANCE III HD systems in particular benefit from new power management features that display the state of the system and its components, in addition to providing push-button system start-up and shutdown. The ParaVision 6 true 64-bit architecture and parallel multi-core acquisition and reconstruction deliver high-resolution 3D images up to virtually unlimited size. Advanced users will welcome the fully integrated method development environment that enables them to redefine their own boundaries in imaging research.
About Bruker Corporation
Bruker Corporation (NAS: BRKR) is a leading provider of high performance scientific instruments and solutions for molecular and materials research, as well as for diagnostics, industrial, clinical and applied analysis.
For more information: www.bruker.com
For more information on ParaVision 6: www.bruker.com/ParaVision.
For more information on Bruker at WMIC: www.bruker.com/WMIC
Photos/Multimedia Gallery Available:http://www.businesswire.com/multimedia/home/20130918005165/en/
Bruker
Dr. Thorsten Thiel, +49 (721) 5161 - 6500
Director of Marketing Communications
thorsten.thiel@bruker.com
KEYWORDS: United States North America Georgia
INDUSTRY KEYWORDS:
The article Bruker Sets New Standards in Preclinical Imaging Software with ParaVision 6 originally appeared on Fool.com.
Try any of our Foolish newsletter services free for 30 days. We Fools may not all hold the same opinions, but we all believe that considering a diverse range of insights makes us better investors. The Motley Fool has a disclosure policy.
Copyright © 1995 - 2013 The Motley Fool, LLC. All rights reserved. The Motley Fool has a disclosure policy.
